Nektar Therapeutics | NKTR - Ingresos Por Ventas





Ventas Cambio Fecha
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
ALKERMES USD 392.91M 8.41M 2026-03
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amgen USD 8.62B 1.28B 2026-03
Baxter International USD 2.7B 270M 2026-03
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Biogen USD 2.25B 30M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cipla INR 65.41B 9.77B 2026-03
Dr.Reddys Laboratories INR 75.46B 11.81B 2026-03
Eisai JPY 205.43B 14.51B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Exelixis USD 610.8M 12.14M 2026-03
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Grifols EUR 2B 306.7M 2026-03
Halozyme Therapeutics USD 377M 74.76M 2026-03
Incyte USD 1.27B 240M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Ironwood Pharmaceuticals USD 106.51M 58.8M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
MacroGenics USD 20.8M 20.43M 2026-03
Merck USD 16.29B 110M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Neurocrine Biosciences USD 811M 5.5M 2026-03
Novartis USD 13.11B 226M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Takeda JPY 1.09T 100B 2026-03
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03
Xencor USD 4.51M 23.73M 2026-03